Organon & Co. shares rise 3.45% intraday after HKEX censures Henlius Biotech, rebukes former CEO.

miércoles, 3 de septiembre de 2025, 3:57 pm ET1 min de lectura
OGN--
Organon & Co. rose 3.45% in intraday trading. The news event about HKEX censuring Henlius Biotech and rebuking its former CEO is not directly related to Organon & Co. Therefore, the cause of the stock's movement is not clear from the given news events.

Organon & Co. shares rise 3.45% intraday after HKEX censures Henlius Biotech, rebukes former CEO.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios